Literature DB >> 26860500

Proton pump inhibitors and fracture: they impair bone quality and increase fall risk?

T Sugiyama1, K Watarai2, T Oda2, Y T Kim2, H Oda2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26860500     DOI： 10.1007/s00198-016-3509-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  16 in total

Review 1.  Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies.

Authors:  Wisit Cheungpasitporn; Charat Thongprayoon; Wonngarm Kittanamongkolchai; Narat Srivali; Peter J Edmonds; Patompong Ungprasert; Oisin A O'Corragain; Sira Korpaisarn; Stephen B Erickson
Journal:  Ren Fail       Date:  2015-06-25       Impact factor: 2.606

Review 2.  Association between vitamin B12 deficiency and long-term use of acid-lowering agents: a systematic review and meta-analysis.

Authors:  S B Jung; V Nagaraja; A Kapur; G D Eslick
Journal:  Intern Med J       Date:  2015-04       Impact factor: 2.048

3.  Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.

Authors:  Benjamin Lazarus; Yuan Chen; Francis P Wilson; Yingying Sang; Alex R Chang; Josef Coresh; Morgan E Grams
Journal:  JAMA Intern Med       Date:  2016-02       Impact factor: 21.873

Review 4.  Efficacy and safety of odanacatib treatment for patients with osteoporosis: a meta-analysis.

Authors:  Shi Feng; Zhicheng Luo; Da Liu
Journal:  J Bone Miner Metab       Date:  2014-07-05       Impact factor: 2.626

5.  Proton-pump inhibitors and risk of fractures: an update meta-analysis.

Authors:  B Zhou; Y Huang; H Li; W Sun; J Liu
Journal:  Osteoporos Int       Date:  2016-01       Impact factor: 4.507

6.  Association of Proton Pump Inhibitor Use with Recurrent Falls and Risk of Fractures in Older Women: A Study of Medication Use in Older Fallers.

Authors:  H W Thaler; C S Sterke; T J M van der Cammen
Journal:  J Nutr Health Aging       Date:  2016-01       Impact factor: 4.075

Review 7.  The relationship between long-term proton pump inhibitor therapy and skeletal frailty.

Authors:  Arthur N Lau; Michael Tomizza; Matthew Wong-Pack; Alexandra Papaioannou; Jonathan D Adachi
Journal:  Endocrine       Date:  2015-05-07       Impact factor: 3.633

Review 8.  Magnesium in man: implications for health and disease.

Authors:  Jeroen H F de Baaij; Joost G J Hoenderop; René J M Bindels
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

Review 9.  Low bone mineral density and fractures in stages 3-5 CKD: an updated systematic review and meta-analysis.

Authors:  R C Bucur; D D Panjwani; L Turner; T Rader; S L West; S A Jamal
Journal:  Osteoporos Int       Date:  2014-12-05       Impact factor: 4.507

Review 10.  The Role of B-Vitamins in Bone Health and Disease in Older Adults.

Authors:  Regan L Bailey; Janneke P van Wijngaarden
Journal:  Curr Osteoporos Rep       Date:  2015-08       Impact factor: 5.096
View more
  3 in total

1.  Proton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis.

Authors:  Yousef Nassar; Seth Richter
Journal:  J Bone Metab       Date:  2018-08-31

Review 2.  Establishing the Association Between Osteoporosis and Peptic Ulcer Disease: A Systematic Review.

Authors:  Sneha Teresa Selvin; Sonu Thomas; Viktoriya Bikeyeva; Ahmed Abdullah; Aleksandra Radivojevic; Anas A Abu Jad; Anvesh Ravanavena; Chetna Ravindra; Emmanuelar O Igweonu-Nwakile; Safina Ali; Salomi Paul; Shreyas Yakkali; Prachi Balani
Journal:  Cureus       Date:  2022-07-23

Review 3.  Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.

Authors:  Lingaku Lee; Irene Ramos-Alvarez; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Mol Sci       Date:  2019-10-16       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.